← Eichor
Study identifier: NCT06882356 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Glaucoma and Retinopathy Screening Study

Condition: Glaucoma  ·  Sponsor: Massachusetts Eye and Ear Infirmary

PhaseNA
Planned participants2000
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset

This description comes directly from the study's public registry record.

Talk to the study team

David S Friedman, MD, PhD, MPH  ·  617-573-3094  ·  grass@mgb.org

Always discuss trial participation with your own doctor first.

Locations (5)

Brigham and Women's Primary Care Associates of LongwoodBoston, Massachusetts, United StatesRecruiting
MGH Chelsea HealthCare CenterChelsea, Massachusetts, United StatesRecruiting
NSPG LynnLynn, Massachusetts, United StatesRecruiting
NSPG SalemSalem, Massachusetts, United StatesNot Yet Recruiting
NSPG SaugusSaugus, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06882356